To investigate whether chemotherapy‐shaped host immune status, rather than a direct impact of chemotherapy on the tumor microenvironment, accounted for the enhanced response to anti‐PD‐1 therapy, we carried out a sequential treatment experiment. This evidence concerns the gene PDCD1 and neoplasm.